cdmo.directory
← Compare landing

OMISAN S.p.A. vs Unither Pharmaceuticals

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/omisan/unither-pharma

CategoryOMISAN S.p.A.Unither Pharmaceuticals
Listed sitecdmocdmo
SummaryItalian maker of sterile ophthalmic medical devices, including eye drops, sprays, eyewashes, and contact lens solutions. Offers private label and CDMO manufacturing for ophthalmic multinationals, with preservative-free dispensing technologies.Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.
Services
  • Ophthalmic Manufacturing
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Technology Transfer
  • Process Development
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Ophthalmic Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Oral Solid Dosage Manufacturing
  • CMC Regulatory Submission Support
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Ophthalmology
  • Rare Disease
  • Respiratory
  • Ophthalmology
Locations
  • Headquarters, Guidonia Montecelio, RM, Italy
  • Headquarters, Gannat, Allier, France
  • Manufacturing, Rochester, New York, United States
  • Manufacturing, Brazil
  • Manufacturing, China
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.